The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Next-generation superparamagnetic iron oxide nanoparticles for cancer theranostics
Open accessAbstract
Superparamagnetic iron oxide (SPIO) nanoparticles have been intensively studied for the development of contrast agents in MRI. First-generation SPIO nanoparticles had diagnostic capabilities only, whereas a new generation of SPIO nanoparticle has multifunctional characteristics for combined therapeutic and diagnostic applications. These theranostic nanoparticles hold great potential for image-guided cancer therapies. In particular, polymer-coated theranostic SPIO nanoparticles have enjoyed increasing attention as a result of good biocompatibility, biodegradability and versatile functionality endowed by polymeric matrices. This review provides an overview of recently developed polymer-coated multifunctional SPIO nanoparticles for cancer theranostics and discusses current challenges and future perspectives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“SPION have been loaded with many different therapeutics drugs. Especially anticancer agents have been employed, ranging from standard low molecular weight chemotherapeutics, such as doxorubicin, to more advanced therapeutic compounds, such as siRNA [237, 238].”
From Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications (2019) · cites this paper as [238]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer
Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., van de Kaa, C. H., de la Rosette, J., & Weissleder, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022749 · Cited by 1,971
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,759
Zanganeh, S., Hutter, G., Spitler, R., Lenkov, O., Mahmoudi, M., Shaw, A., Pajarinen, J. S., Nejadnik, H., Goodman, S., Moseley, M., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.168 · Cited by 1,647
Self-citationLe Tourneau, C., Delord, J.-P., Gonçalves, A., Gavoille, C., Dubot, C., Isambert, N., Campone, M., Trédan, O., Massiani, M.-A., Mauborgne, C., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00188-6 · Cited by 1,137
Molecular targeted therapies in hepatocellular carcinoma†
Llovet, J. M., & Bruix, J. (2008) · Hepatology · doi:10.1002/hep.22506 · Cited by 1,011
Polymer-encapsulated organic nanoparticles for fluorescence and photoacoustic imaging
Li, K., & Liu, B. (2014) · Chemical Society Reviews · doi:10.1039/c4cs00014e · Cited by 1,000
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Siegel, 2016, Cancer statistics, CA. Cancer J. Clin., 66, 7
Cited by
Sorted by citations
Items 101–139 of 139
Bioinspired nanoparticles-based drug delivery systems for cancer theranostics
Madamsetty, V. S., Mukherjee, A., & Paul, M. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821467-1.00008-2 · Cited by 6
Nanoparticles in Cancer Treatment: A Narrative Review
Hassan, T., Huang, X., Zhou, C. Z., Khan, M. S. G., & Saeed, S. (2022) · Proceedings of the Pakistan Academy of Sciences B Life and Environmental Sciences · doi:10.53560/ppasb(58-3)664 · Cited by 7
Current Developments of Iron Oxide Nanomaterials as MRI Theranostic Agents for Pancreatic Cancer
Cheng, F., Tomanek, B., & Błasiak, B. (2025) · Journal of Nanotheranostics · doi:10.3390/jnt6030022 · Cited by 5
de Souza, F. G., de Lima, N. R. B., Roullin, G., Pal, K., & da Silva, N. D. (2021) · Current Radiopharmaceuticals · doi:10.2174/1874471014999210128183231 · Cited by 5
Formation and investigation of the biology of nanocomposite coated with chitosan-modified oleic acid
Mahmoudi, R., Esmaeili, A., & Nematollahzadeh, A. (2023) · Sustainable Chemistry and Pharmacy · doi:10.1016/j.scp.2023.101029 · Cited by 5
The Magnetic Nanobased Strategies to Overcome Drug Resistance in Breast Cancer Therapy
Yalçın, S., & Gündüz, U. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813351-4.00033-x · Cited by 5
Advances in Magnetic Nanoparticle-Driven Delivery of Gene Therapies towards Prostate Cancer
Panday, R., Abdalla, A. M. E., Neupane, M., Khadka, S., Kricha, A., & Yang, G. (2021) · Journal of Nanomaterials · doi:10.1155/2021/6050795 · Cited by 5
A Dual‐Mode Imaging Nanoparticle Probe Targeting PD‐L1 for Triple‐Negative Breast Cancer
Li, X., Ji, Y., Chen, M., Zhang, S., Wang, Z., Su, D., & Luo, N. (2022) · Contrast Media & Molecular Imaging · doi:10.1155/2022/2431026 · Cited by 5
The Evolution of Iron Oxide Nanoparticles as MRI Contrast Agents
O’Shea, A., Parakh, A., Lahoud, R. M., Hedgire, S., & Harisinghani, M. G. (2020) · MRS Advances · doi:10.1557/adv.2020.311 · Cited by 6
New progress in tumor treatment based on nanoparticles combined with irreversible electroporation
Xu, L., Xie, L., Fang, C., Lou, W., & Jiang, T. (2022) · Nano Select · doi:10.1002/nano.202200064 · Cited by 4
Bovine Lactoferrin Loaded Magnetic-Responsive Plasmonic Lipo-Somes for Therapeutic ApplicationsPreprint
Pereira, M., Rodrigues, A. R. O., Amaral, L., Côrte‐Real, M., Santos‐Pereira, C., & Castanheira, E. M. S. (2023) · Preprints.org · doi:10.20944/preprints202305.1868.v1 · Cited by 4
Kong, X., Cheng, R., Zhang, W., Lu, Y., Kan, Y., Fang, Y., Gao, J., Wang, J., & Hwang, K. C. (2026) · Drug Resistance Updates · doi:10.1016/j.drup.2026.101392 · Cited by 4
Ellingson, B. M., Wen, P. Y., & Cloughesy, T. F. (2021) · The Cancer Journal · doi:10.1097/ppo.0000000000000543 · Cited by 3
Cutting-edge Nanotechnological Approaches for Lung Cancer Therapy
Bhattacharya, S., & Agrawal, A. (2022) · Current Drug Research Reviews · doi:10.2174/2589977514666220418085658 · Cited by 3
Chemical and cellular characterization of SPIONs stabilized with sodium citrate
Cândido, M. A., Jesus, V. P. S., Vieira, P. F. A., Campos, A. P. C., & Raniero, L. J. (2024) · Research on Biomedical Engineering · doi:10.1007/s42600-024-00384-1 · Cited by 3
Senna, M. (2004) · CRC Press eBooks · doi:10.1201/9781439834398.ch87 · Cited by 3
Construction of a visualized liver-targeting siRNA delivery system
Sun, D., Jin, G., Jin, Z., Jin, Y. J., Sun, J., Han, L., & Quan, J.-S. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104566 · Cited by 2
Dual-Peak Lorentzian CEST MRI for antiretroviral drug brain distribution
Liu, Y., Gauthier, G. C., Gendelman, H. E., & Bade, A. N. (2022) · NeuroImmune Pharmacology and Therapeutics · doi:10.1515/nipt-2022-0012 · Cited by 2
Inorganic-based nanotheranostics: current status and challenges
Nayak, A. K., Hasnain, M. S., & Aminabhavi, T. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85784-0.00018-2 · Cited by 2
Polymer-Based Tumor-targeted Nanosystems
Benli‐Hoppe, T., & Wagner, E. (2020) · Springer eBooks · doi:10.1007/978-981-15-5159-8_11 · Cited by 2
Synthesis of 99mtc(V)-DMSA and radiolabelling of SPIO nanoparticles
Sintya, E. (2018) · IOP Conference Series Materials Science and Engineering · doi:10.1088/1757-899x/434/1/012152 · Cited by 1
Review on Targeted Drug Delivery in Pancreatic Cancer
Pinisetti, C., & Arora, V. (2021) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2021/v33i60b34822 · Cited by 1
Akhtar, H., Ijaz, K., Ikram, F., Omema, U., Khan, A. S., Akhtar, S., Alhamoudi, F. H., Rehman, I. U., & Chaudhry, A. A. (2025) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2025.114988 · Cited by 1
Nanoparticle-based theranostics in cancer
Das, P., & Das, M. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821712-2.00011-6 · Cited by 1
Applications of Colloidal Nanocrystals
(2021) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016568-00209 · Cited by 1
Application of nanotheranostics in cancer
Azad, A. K., Ping, N. Y., Hasnain, M. S., & Nayak, A. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89953-6.00004-0 · Cited by 1
Feng, X., Gao, D., Zhou, J., Gui, Z., Cai, A., Wang, J., Dai, J., Jing, Y., Qian, J., Cui, Z., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.155830 · Cited by 1
Li, Y., Tian, W., Chen, C., Liu, H., Zhang, Z.-F., & Wang, C. (2025) · Applied Organometallic Chemistry · doi:10.1002/aoc.70214 · Cited by 1
Stromal reprogramming in solid tumors by nanoparticles: A review
Altalbawy, F. M. A., Hussein, U. A., Ballal, S., Chahar, M., Darwish, N. S. A., Saini, S., Prasad, G. V. S., Rizaev, J. A., Al-Anbari, H. H. A., Saud, M. J., et al. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108794 · Cited by 1
CANCER DIAGNOSTICS, IMAGING AND TREATMENT BY NANOSCALE STRUCTURES TARGETING
Özcan, Ö. Ö. (2019) · Biotechnologia Acta · doi:10.15407/biotech12.06.012 · Cited by 1
Monodisperse magnetite nanoparticles with high sensitivity as MRI contrast agents
Amato, E., Lanzafame, P., Italiano, A., Cicero, G., Papanikolaou, G., Perathoner, S., Centi, G., & Minutoli, F. (2018) · Atti della Accademia Peloritana dei Pericolanti. Classe di Scienze Fisiche, Matematiche e Naturali/Atti della Accademia Peloritana dei Pericolanti, Classe di Scienze Fisiche, Matematiche e Naturali · doi:10.1478/aapp.962a5
In Vitro Evaluation of Paclitaxel Loaded Magnetic Nanoparticles for Breast Cancer Therapy
Ursachi, V.-C., Mihai, C., Nastuta, A. V., Dimitriu, D. C., Vereștiuc, L., & Bălan, V. (2021) · E-Health and Bioengineering Conference (EHB) · doi:10.1109/ehb52898.2021.9657671
Ramezankhani, M., Olfatbakhsh, T., Ashkarran, A. A., Zeki, D. A., Radu, I., Khalighinejad, F., Keihanian, K., Ionete, C., Milani, A. S., Mahmoudi, M., et al. (2022) · Preprints.org · doi:10.20944/preprints202211.0187.v1
Asey, M. N., Abdullah, C. A. C., Abdelmonem, M., Esa, N. M., & Rahman, M. B. A. (2025) · Macromolecular Symposia · doi:10.1002/masy.202400237
Iron oxide nanoparticles empowering melanoma therapy: advances in multifunctional platform research
Bai, X., Wang, Z., Cao, Z., & Zhen, J. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1655677
Polymers (natural and artificial) for theranostic applications
de Carvalho, L. T., Lopes, L. R., Cesquim, M. G., Machado, W. F., da Silva, M. B., Vieira, T. A., Vasquez, R., Donato, G. D., & Medeiros, S. F. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-26608-9.00009-3 · Cited by 1
Luo, W., Yang, X., Wang, Y., Xu, J., Lou, Y., Chen, J., Hou, J., Wang, X., 鲁远飞, Mao, J., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04725-3
Theranostic nanoparticles for advanced cancer therapy
Mohapatra, D., Sharma, D., & Verma, R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44185-1.00035-5
Metadata
- Authors
- Li, K., Nejadnik, H., & Daldrup-Link, H. E.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Li, Kai
- Daldrup-Link, Heike E.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2017-09
- Volume
- 22
- Issue
- 9
- Pages
- 1421-1429
- ISSN
- 1359-6446 (ISSN-L)
- PMC
- PMC5610947
- OpenAlex
- W2608879075
- Cited by
- 139
- References
- 62
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 12 · 2023: 16 · 2022: 21 · 2021: 24 · 2020: 18 · 2019: 17 · 2018: 17 · 2017: 2
- FWCI
- 1.19
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Drug Discovery Today (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (NCI) (R21CA190196)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (R21AR066302, 2R01AR054458)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (R01 HD081123-01A1)
- Agency for Science, Technology and Research (A*STAR, Singapore)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Characterization and Applications of Magnetic Nanoparticles
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- superparamagnetic iron oxide nanoparticles, theranostics, cancer theranostics, polymer-coated nanoparticles, multifunctional nanoparticles, MRI contrast agents, image-guided cancer therapy, biocompatibility, biodegradability
- MeSH terms
- Theranostic Nanomedicine, Animals, Ferric Compounds, Humans, Hyperthermia, Induced, Neoplasms, Phototherapy, Genetic Therapy, Metal Nanoparticles, Magnetic Phenomena
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
